Generalized morphea in the setting of pembrolizumab

Int J Dermatol. 2019 Jun;58(6):736-738. doi: 10.1111/ijd.14097. Epub 2018 Jun 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Biopsy
  • Choroid Neoplasms / drug therapy
  • Choroid Neoplasms / pathology
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Male
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Middle Aged
  • Prednisone / therapeutic use
  • Scleroderma, Systemic / chemically induced*
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy
  • Skin / drug effects
  • Skin / immunology
  • Skin / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab
  • Prednisone